Patent holdings for IPC class A61K 31/381

Total number of patents in this class: 3613

10-year publication summary

204
176
202
206
216
204
230
169
207
147
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Allergan, Inc.
2339
80
Antecip Bioventures II LLC
339
57
Janssen Pharmaceutica N.V.
3381
44
The Regents of the University of California
20035
36
Novartis AG
10726
28
Bristol-myers Squibb Company
4867
26
Takeda Pharmaceutical Company Limited
2707
25
Sunovion Pharmaceuticals Inc.
263
25
Astellas Pharma Inc.
1083
22
LTS Lohmann Therapie-Systeme AG
707
21
Boehringer Ingelheim International GmbH
4640
19
Dana-Farber Cancer Institute, Inc.
2577
18
Gilead Sciences, Inc.
2042
18
Centre National de La Recherche Scientifique
10498
17
Institut National de La Sante et de La Recherche Medicale (inserm)
2880
17
The General Hospital Corporation
4759
16
Vertex Pharmaceuticals Incorporated
1619
15
Mitsubishi Tanabe Pharma Corporation
581
15
University of Pittsburgh - Of the Commonwealth System of Higher Education
3178
15
F. Hoffmann-La Roche AG
7942
14
Other owners 3085